1. Andreassen CN, Alsner J, Overgaard J. Does variability in normal tissue reactions after radiotherapy have a genetic basis–where and how to look for it? Radiat Oncol J 2002;64:131-140.
2. Brown KR, Rzucidlo E. Acute and chronic radiation injury. J Vasc Surg 2011;53:15S-21S.
3. Deneuve S, Mirjolet C, Bastogne T, Duclos M, Retif P, Zrounba P, et al. Proof of concept of a binary blood assay for predicting radiosensitivity. Cancers 2021;13:2477.
4. Carlotto A, Hogsett VL, Maiorini EM, Razulis JG, Sonis ST. The economic burden of toxicities associated with cancer treatment: Review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue. Pharmacoeconomics 2013;31:753-766.
5. Pixberg C, Koch R, Eich HT, Martinsson U, Kristensen I, Matuschek C, et al. Acute toxicity grade 3 and 4 after irradiation in children and adolescents: Results from the IPPARCA collaboration. Int J Radiat Oncol Biol Phys 2016;94:792-799.
6. Li K, Yang L, Hu Q-y, Chen X-z, Chen M, Chen Y. Oral mucosa dose parameters predicting grade≥ 3 acute toxicity in locally advanced nasopharyngeal carcinoma patients treated with concurrent intensity-modulated radiation therapy and chemotherapy: An independent validation study comparing oral cavity versus mucosal surface contouring techniques. Transl Oncol 2017;10:752-759.
7. Banerjee R, Chakraborty S, Nygren I, Sinha R. Small bowel dose parameters predicting grade≥ 3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: An independent validation study comparing peritoneal space versus small bowel loop contouring techniques. Int J Radiat Oncol Biol Phys 2013;85:1225-1231.
8. Gill S, Thomas J, Fox C, Kron T, Rolfo A, Leahy M, et al. Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy. Radiat Oncol 2011;6:1-7.
9. Herschtal A, Martin RF, Leong T, Lobachevsky P, Martin OA. A bayesian approach for prediction of patient radiosensitivity. Int J Radiat Oncol Biol Phys 2018;102:627-634.
10. Fitzgerald TJ, Wang T, Goel HL, Huang J, Stein G, Lian J, et al. Prostate carcinoma and radiation therapy: therapeutic treatment resistance and strategies for targeted therapeutic intervention. Expert Rev Anticancer Ther 2008;8:967-974.
11. Eschrich SA, Pramana J, Zhang H, Zhao H, Boulware D, Lee J-H, et al. A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. Int J Radiat Oncol Biol Phys 2009;75:489-496.
12. Shahbazian D, Bindra RS, Kluger HM, Glazer PM. Radiation sensitivity and sensitization in melanoma. Pigment Cell Melanoma Res 2013;26:928-930.
13. Ocolotobiche EE, Dauder RM, Güerci AM. Radiosensitivity of radiotherapy patients: The effect of individual DNA repair capacity. Mutat Res-Gen Tox En 2021;867:503371.
14. Yan D, Shen M, Du Z, Cao J, Tian Y, Zeng P, et al. Developing ZNF Gene Signatures Predicting Radiosensitivity of Patients with Breast Cancer. J Oncol 2021;2021: 9255494.
15. Mohammadi C, Khoei SG, Fayazi N, Mohammadi Y, Najafi R. miRNA as promising theragnostic biomarkers for predicting radioresistance in cancer: A systematic review and meta‐analysis. Crit Rev Oncol Hemat 2021;157:103183.
16. Maeda J, Froning CE, Brents CA, Rose BJ, Thamm DH, Kato TA. Intrinsic radiosensitivity and cellular characterization of 27 canine cancer cell lines. PloS One 2016;11:e0156689.
17. Bahreyni-Toossi M-T, Azimian H, Aghaee-Bakhtiari SH, Mahmoudi M, Sadat-Darbandi M, Zafari N. Radiation-induced DNA damage and altered expression of p21, cyclin D1 and Mre11 genes in human fibroblast cell lines with different radiosensitivity. Mutat Res 2021;823:111760.
18. Cox JD. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-1346.
19. Bahreyni-Toossi M-T, Mohamadian N, Ghorbani M, Khorshidi F, Akbari F, Knaup C. Skin dosimetry in radiotherapy of breast cancer: a comparison between EBT and EBT3 radiochromic films. J Biomed Phys Eng 2016;6:51.
20. Kern R, Correa SC, Scandolara TB, Carla da Silva J, Pires BR, Panis C. Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology. J Pers Med 2020;17:399-420.
21. Eschrich SA, Pramana J, Zhang H, Zhao H, Boulware D, Lee J-H, et al. A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. Int J Radiat Oncol Biol Phys 2009;75:489-496.
22. Huang R-X, Zhou P-K. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther 2020;5:1-27.
23. Goodarzi AA, Jeggo PA. Irradiation induced foci (IRIF) as a biomarker for radiosensitivity. Mutat Res 2012;736:39-47.
24. Martin NT, Nahas SA, Tunuguntla R, Fike F, Gatti RA. Assessing ‘radiosensitivity’with kinetic profiles of γ-H2AX, 53BP1 and BRCA1 foci. Radiother Oncol 2011;101:35-38.
25. Djuzenova CS, Elsner I, Katzer A, Worschech E, Distel LV, Flentje M, et al. Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 foci. Radiat Oncol 2013;8:1-12.
26. Kawashima S, Kawaguchi N, Taniguchi K, Tashiro K, Komura K, Tanaka T, et al. γ‑H2AX as a potential indicator of radiosensitivity in colorectal cancer cells. Oncol Lett 2020;20:2331-2337.
27. Chua MLK, Horn S, Somaiah N, Davies S, Gothard L, A’Hern R, et al. DNA double-strand break repair and induction of apoptosis in ex vivo irradiated blood lymphocytes in relation to late normal tissue reactions following breast radiotherapy. Radiat Environ Biophys. 2014;53:355-364.
28. Mumbrekar KD, Fernandes DJ, Goutham HV, Sharan K, Vadhiraja BM, Satyamoorthy K, et al. Influence of double-strand break repair on radiation therapy-induced acute skin reactions in breast cancer patients. Int J Radiat Oncol Biol Phys 2014;88:671-676.
29. Goutham HV, Mumbrekar KD, Vadhiraja BM, Fernandes DJ, Sharan K, Parashiva GK, et al. DNA double-strand break analysis by γ-H2AX foci: a useful method for determining the overreactors to radiation-induced acute reactions among head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 2012;84:e607-e612.
30. Granzotto A, Benadjaoud MA, Vogin G, Devic C, Ferlazzo ML, Bodgi L, et al. Influence of nucleoshuttling of the ATM protein in the healthy tissues response to radiation therapy: toward a molecular classification of human radiosensitivity. Int J Radiat Oncol Biol Phys 2016;94:450-460.
31. Bahreyni-Toossi M-T, Azimian H, Sarrafzadeh O, Mohebbi S, Soleymanifard S. Automatic detection of micronuclei by cell microscopic image processing. Mutat Res 2017;806:9-18.
32. Pouliliou SE, Lialiaris TS, Dimitriou T, Giatromanolaki A, Papazoglou D, Pappa A, et al. Survival fraction at 2 Gy and γH2AX expression kinetics in peripheral blood lymphocytes from cancer patients: Relationship with acute radiation-induced toxicities. Int J Radiat Oncol Biol Phys 2015;92:667-674.
33. Mahmoud AS, Hassan AM, Ali AA, Hassan NM, Yousif AA, Elbashir FE, et al. Detection Of radiation-induced DNA damage in breast cancer patients by using gamma H2AX biomarker: A possible correlation with their body mass index. Genome Integr 2022;13:1.
34. Bulat T, Keta O, Korićanac L, Žakula J, Petrović I, Ristić-Fira A, et al. Radiation dose determines the method for quantification of DNA double strand breaks. An Acad Bras Cienc. 2016;88:127-136.
35. Raavi V, Perumal V, Paul SF. Potential application of γ-H2AX as a biodosimetry tool for radiation triage. Mutat Res Rev Mutat Res 2021;787:108350.
36. Bourton EC, Plowman PN, Smith D, Arlett CF, Parris CN. Prolonged expression of the γ‐H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment. Int J Cancer 2011;129:2928-2934.
37. Beaton LA, Marro L, Malone S, Samiee S, Grimes S, Malone K, et al. Investigating γ H2AX as a biomarker of radiosensitivity using flow cytometry methods. ISRN Radiol. 2013;2013:704659.